Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

VISX Excimer Laser System approved in Japan

May 11, 1998

No Comments

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

No Comments

First market introduction for Alcon's newest ophthalmic drug

May 5, 1998

No Comments

Update on Repligen's angiogenesis inhibitors

May 1, 1998

No Comments

CyDex and Allergan sign option for ophthalmic drug delivery technology

April 29, 1998

No Comments

New antiglaucoma agent approved in U.S.

April 24, 1998

No Comments

Another European launch for Alphagan

April 23, 1998

No Comments

Akorn acquires ophthalmic products from Alza

April 20, 1998

No Comments

Cosopt receives marketing approval from FDA

April 16, 1998

No Comments

Bio-Technology General signs U.S. marketing agreement with Akorn for BioLon

April 15, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

VISX Excimer Laser System approved in Japan

Novo Nordisk discovers potent sst4 receptor agonist

First market introduction for Alcon's newest ophthalmic drug

Update on Repligen's angiogenesis inhibitors

CyDex and Allergan sign option for ophthalmic drug delivery technology

New antiglaucoma agent approved in U.S.

Another European launch for Alphagan

Akorn acquires ophthalmic products from Alza

Cosopt receives marketing approval from FDA

Bio-Technology General signs U.S. marketing agreement with Akorn for BioLon

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

Ocular RSS

Ocular
RSS